Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at 9.49,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof14.79 indicates a potential upside of 55.9%.The mean estimate comprises 14 short-term price targets with a standard deviation of 3.79.Whilethelowestestimateof11 indicates a 15.9% increase from the current pri ...